Blog series: ME/CFS research in focus
The causes for ME/CFS are not known, which makes it difficult to treat this disease. Biomedical research should change that. advance effective treatment for ME/CFS. In the blog series 'ME/CFS research in focus', researchers share more about what their research entails and which results are to be expected.
The studies covered in this blog series are funded by the ZonMw ME/CFS research programme. The aim of that programme is to improve the health, quality of life and social position of ME/CFS patients.
10 studies, 2 consortia
The 10 studies in this blog series are part of 2 'consortia'. Within these partnerships, parties cooperate with each other in carrying out biomedical research into ME/CFS. The consortia also ensure data exchange and manage the biobanks, in which body materials of patients are collected that are used for further research. Within the ME/CFS research programme, ZonMw funds the NNMCB consortium and the ME/CFS Lines consortium. In this interview, the consortium leaders tell more about their collaboration.
Blog 1: Understanding ME/CFS better by monitoring symptoms after exertion
Blog 2: Learning from post-infectious diseases for better treatment of ME/CFS
Blog 3: Could genes be the key to finding what causes ME/CFS?
Blog 4: Customised treatment for ME/CFS using immune signatures
Blog 5: What changes in skeletal muscles and blood of people with ME/CFS and post-exertional malaise
Blog 6: Is a disrupted immune response to bacteria and viruses a factor in ME/CFS?
Blog 7: Do antibodies that target the patient’s own body cause ME/CFS?
Blog 8: ‘Let’s not forget children in research on immune system disruption and ME/CFS'
Blog 9: Changes in the brains of patients with ME/CFS
Blog 10: Do changes in gut bacteria cause the onset of ME/CFS?
Text: Ilse Bos, Photography: Robert Tjalondo